| | |
Japanese
|
Total
| |
Males
| |
Females
| |
|---|
| | |
References
|
n
|
M ± SD
|
n
|
M ± SD
|
n
|
M ± SD
|
|
Serum
| | | | | | | | |
|
Albumin
|
g/dL
|
3.8–5.3
|
135
|
4.3 ± 0.4
|
72
|
4.3 ± 0.4
|
63
|
4.3 ± 0.3
|
|
ALT
|
IU/L
|
5–35
|
135
|
27.2 ± 24.4
|
72
|
30.4 ± 28.1
|
63
|
24.4 ± 19.4
|
|
BUN
|
mg/dL
|
8.0–23
|
135
|
14.3 ± 4.3
|
72
|
15.1 ± 4.3
|
63
|
13.5 ± 4.1
|
|
Fe
|
μg/dL
|
M50-200, F40-180
|
71
|
104.6 ± 39.4
|
39
|
119.8 ± 39.7
|
32
|
86.0 ± 30.3
|
|
Uric acid
|
mg/dL
|
M3.8-7.5, F2.4-5.8
|
135
|
4.8 ± 1.4
|
72
|
5.4 ± 1.4
|
63
|
4.1 ± 1.0
|
|
Folic acid
|
ng/mL
|
>3.1
|
71
|
4.1 ± 1.6
|
39
|
3.7 ± 1.3
|
32
|
4.6 ± 1.8
|
|
Vitamin A
|
IU/dL
|
97–316
|
71
|
158.7 ± 56.1
|
39
|
180.6 ± 61.2
|
32
|
132.0 ± 34.3
|
|
Vitamin C
|
μ g/mL
|
5.5–16.8
|
66
|
3.5 ± 2.3
|
39
|
3.3 ± 2.6
|
27
|
3.7 ± 2.4
|
| | |
(Japanese Subjects
|
44
|
11.4 ± 5.6
|
26
|
8.7 ± 6.2
|
18
|
14.1 ± 5.3)
|
|
Vitamin E
|
mg/dL
|
0.75–1.41
|
38
|
0.9 ± 0.3
|
20
|
0.8 ± 0.2
|
18
|
1.0 ± 0.3
|
|
MDA
|
U/L
|
Japanese Subjects
|
66
|
109.5 ± 47.7
|
39
|
117.2 ± 49.3
|
27
|
98.4 ± 43.7
|
| | |
Total (n = 44) 62.5 ± 21.3
| | | | | | |
| | |
Males (n = 26) 74.6 ± 25.5
| | | | | | |
| | |
Females (n = 18) 51.8 ± 17.2
| | | | | | |
|
Urine
| | | | | | | | |
|
8-OHdG
|
ng/mgCre
|
Japanese Subjects
|
78
|
11.8 ± 3.4
|
47
|
11.3 ± 3.0
|
31
|
12.1 ± 5.7
|
| | |
Total (n = 32) 6.8 ± 4.4
| | | | | | |
| | |
Males (n = 20) 7.5 ± 4.8
| | | | | | |
| | |
Females (n = 12) 5.5 ± 4.3
| | | | | | |
- ALT: alanine aminotransferase, MDA: malondialdehyde-modified LDL, BUN: blood urea nitrogen, Fe: iron, 8-OHdG: urinary 8-hydroxy-2'-deoxyguanosine Japanese References: the data of a commercial laboratory, the SRL Inc. (Tokyo, Japan). *** p < 0.001
